Literature DB >> 20832401

Loss of retinal function in aged DBA/2J mice - New insights into retinal neurodegeneration.

Peter Heiduschka, Sylvie Julien, Frank Schuettauf, Sven Schnichels.   

Abstract

The DBA/2J mouse is a common animal model of glaucoma. The intraocular pressure increases with age, and retinal ganglion cells (RGC) degenerate, usually starting at an age of approximately six months. In this study, we used two-year-old DBA/2J mice presuming an end-point of RGC degeneration. We investigated visual function in these animals using electroretinography (ERG) and visual evoked potentials (VEP), and we checked the number of remaining RGC by retrograde staining. Almost no RGC were left in the retina, and VEP were hardly recordable. Surprisingly, also ERG amplitudes of scotopic a-waves and b-waves, photopic b-waves and oscillatory potentials were decreased significantly by approximately 40% compared to amplitudes measured in age-matched C57BL/6J mice. The latencies were not changed in DBA/2J mice compared to C57BL/6J mice, and so were the ratios between amplitudes of a-waves, b-waves and oscillatory potentials. Our results indicate that, in addition to degeneration of RGC, also photoreceptors are affected by pathological processes in the eye caused by the mutations present in DBA/2J mice.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832401     DOI: 10.1016/j.exer.2010.09.001

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  26 in total

1.  Contribution of retinal ganglion cells to the mouse electroretinogram.

Authors:  Benjamin J Smith; Xu Wang; Balwantray C Chauhan; Patrice D Côté; François Tremblay
Journal:  Doc Ophthalmol       Date:  2014-06       Impact factor: 2.379

2.  Differential progression of structural and functional alterations in distinct retinal ganglion cell types in a mouse model of glaucoma.

Authors:  Luca Della Santina; Denise M Inman; Caroline B Lupien; Philip J Horner; Rachel O L Wong
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

Review 3.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

Review 4.  Electrophysiological assessment of retinal ganglion cell function.

Authors:  Vittorio Porciatti
Journal:  Exp Eye Res       Date:  2015-05-18       Impact factor: 3.467

Review 5.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

6.  Loss of outer retinal neurons and circuitry alterations in the DBA/2J mouse.

Authors:  Laura Fernández-Sánchez; Luis Pérez de Sevilla Müller; Nicholas C Brecha; Nicolás Cuenca
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-12       Impact factor: 4.799

7.  Neuroglobin is an endogenous neuroprotectant for retinal ganglion cells against glaucomatous damage.

Authors:  Xin Wei; Zhanyang Yu; Kin-Sang Cho; Huihui Chen; Muhammad Taimur A Malik; Xiaoming Chen; Eng H Lo; Xiaoying Wang; Dong F Chen
Journal:  Am J Pathol       Date:  2011-10-01       Impact factor: 4.307

8.  Pressure-dependent modulation of inward-rectifying K+ channels: implications for cation homeostasis and K+ dynamics in glaucoma.

Authors:  Rachel A Fischer; Abigail L Roux; Lauren K Wareham; Rebecca M Sappington
Journal:  Am J Physiol Cell Physiol       Date:  2019-06-05       Impact factor: 4.249

9.  Regional choroidal blood flow and multifocal electroretinography in experimental glaucoma in rhesus macaques.

Authors:  T Michael Nork; Charlene B Y Kim; Kaitlyn M Munsey; Ryan J Dashek; James N Ver Hoeve
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-04       Impact factor: 4.799

10.  Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.

Authors:  Benjamin J Frankfort; A Kareem Khan; Dennis Y Tse; Inyoung Chung; Ji-Jie Pang; Zhuo Yang; Ronald L Gross; Samuel M Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.